JP2014505061A5 - - Google Patents

Download PDF

Info

Publication number
JP2014505061A5
JP2014505061A5 JP2013550864A JP2013550864A JP2014505061A5 JP 2014505061 A5 JP2014505061 A5 JP 2014505061A5 JP 2013550864 A JP2013550864 A JP 2013550864A JP 2013550864 A JP2013550864 A JP 2013550864A JP 2014505061 A5 JP2014505061 A5 JP 2014505061A5
Authority
JP
Japan
Prior art keywords
peptide according
peptide
inflammation
treatment
wounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013550864A
Other languages
English (en)
Japanese (ja)
Other versions
JP6158712B2 (ja
JP2014505061A (ja
Filing date
Publication date
Priority claimed from EP11152213A external-priority patent/EP2481751A1/en
Application filed filed Critical
Publication of JP2014505061A publication Critical patent/JP2014505061A/ja
Publication of JP2014505061A5 publication Critical patent/JP2014505061A5/ja
Application granted granted Critical
Publication of JP6158712B2 publication Critical patent/JP6158712B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013550864A 2011-01-26 2012-01-25 新規合成ペプチド及びそれらの使用 Expired - Fee Related JP6158712B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11152213.2 2011-01-26
EP11152213A EP2481751A1 (en) 2011-01-26 2011-01-26 Human lactoferrin derived peptides
PCT/EP2012/051111 WO2012101156A2 (en) 2011-01-26 2012-01-25 New synthetic peptides and their use

Publications (3)

Publication Number Publication Date
JP2014505061A JP2014505061A (ja) 2014-02-27
JP2014505061A5 true JP2014505061A5 (enExample) 2015-03-12
JP6158712B2 JP6158712B2 (ja) 2017-07-05

Family

ID=44123487

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013550865A Expired - Fee Related JP6158713B2 (ja) 2011-01-26 2012-01-25 ヒトラクトフェリン由来ペプチド及びその使用
JP2013550864A Expired - Fee Related JP6158712B2 (ja) 2011-01-26 2012-01-25 新規合成ペプチド及びそれらの使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013550865A Expired - Fee Related JP6158713B2 (ja) 2011-01-26 2012-01-25 ヒトラクトフェリン由来ペプチド及びその使用

Country Status (13)

Country Link
US (2) US9132165B2 (enExample)
EP (3) EP2481751A1 (enExample)
JP (2) JP6158713B2 (enExample)
KR (2) KR101933900B1 (enExample)
CN (2) CN103476792B (enExample)
AU (2) AU2012210564B2 (enExample)
BR (2) BR112013018264A2 (enExample)
CA (2) CA2825246A1 (enExample)
ES (2) ES2645959T3 (enExample)
MX (2) MX342313B (enExample)
PL (1) PL2668205T3 (enExample)
RU (2) RU2593757C2 (enExample)
WO (2) WO2012101156A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2481751A1 (en) * 2011-01-26 2012-08-01 PharmaSurgics in Sweden AB Human lactoferrin derived peptides
GB201401877D0 (en) * 2014-02-04 2014-03-19 Univ Tromsoe Peptides
CN104888202A (zh) * 2014-05-22 2015-09-09 闫牧乔 一种治疗扁桃体炎的药物
IT201800002457A1 (it) * 2018-02-07 2019-08-07 Neilos S R L Composizione per la prevenzione e il trattamento delle affezioni delle vie respiratorie
RU2681216C1 (ru) * 2018-09-05 2019-03-05 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ стимуляции регенерации инфицированных ран кожи и мягких тканей с применением пептида Gly-His-Lys-D-Ala
RU2681310C1 (ru) * 2018-09-05 2019-03-06 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ первичной хирургической обработки инфицированных ран кожи и мягких тканей с использованием пептида Gly-His-Lys-D-Ala
US12295990B2 (en) 2018-11-09 2025-05-13 The Wistar Institute Of Anatomy And Biology Use of lactoferrin for generating myeloid-derived suppressor cells
KR102032945B1 (ko) * 2018-12-03 2019-10-16 순천대학교 산학협력단 항염증 활성을 나타내는 펩타이드 및 이를 유효성분으로 포함하는 항염증용 조성물
NL2024839B1 (en) * 2020-02-05 2021-09-13 Cbmr Scient Nanoscience B V Antimicrobial peptide for treatment and controlling skin disorders relating to microbial infection

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2818056B2 (ja) 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
US5656591A (en) 1992-01-23 1997-08-12 Morinaga Milk Industry Co., Ltd. Antimicrobial agents and method for treating products therewith
JP3347819B2 (ja) 1993-06-28 2002-11-20 森永乳業株式会社 抗菌性ペプチドの精製方法
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
JP3529423B2 (ja) 1994-04-01 2004-05-24 森永乳業株式会社 抗菌性ペプチドの製造方法
JP3812957B2 (ja) 1994-08-02 2006-08-23 森永乳業株式会社 角膜損傷治療剤
JPH08143468A (ja) 1994-11-17 1996-06-04 Morinaga Milk Ind Co Ltd 抗潰瘍剤
JP2001504447A (ja) 1996-08-12 2001-04-03 エイプラス サイエンス インベスト アーベー ラクトフェリンおよび／またはラクトフェリシンでの、感染、炎症および／または腫瘍の処置および予防
US6696545B1 (en) * 1997-04-11 2004-02-24 Sangstat Medical Corporation Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
SE9804614A0 (en) 1998-07-06 2000-01-07 A+ Science Invest Ab New peptides and use thereof
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
AU5010800A (en) * 1999-05-14 2000-12-05 Regents Of The University Of California, The Anti-inflammatory therapy for inflammatory mediated infection
CA2388910C (en) 1999-11-11 2008-10-07 Am-Pharma B.V. Antimicrobial activity of the first cationic cluster of human lactoferrin
RU2165769C1 (ru) * 2000-07-13 2001-04-27 Якубовская Раиса Ивановна Антибактериальный, антиоксидантный, иммуномодулирующий и антиканцерогенный препарат и способ его применения
SE0102067D0 (sv) 2001-06-11 2001-06-11 A & Science Invest Ab Prevention of neovascularization of intervertebral discs and/or of tissues with local inflammation
US7183381B2 (en) 2004-10-26 2007-02-27 Agennix, Inc. Composition of lactoferrin related peptides and uses thereof
ES2532392T3 (es) * 2006-07-10 2015-03-26 Pba3 Biomed Gmbh Péptidos antimicrobianos
JP5384948B2 (ja) * 2007-02-09 2014-01-08 ジェノミディア株式会社 新規ポリペプチド及びそれを有効成分として含有する抗菌剤
JP5444544B2 (ja) * 2007-02-09 2014-03-19 ジェノミディア株式会社 血管新生誘導剤及びそれに用いられるポリペプチド
EP2050461A1 (en) 2007-10-19 2009-04-22 PharmaSurgics in Sweden AB Peptides based on the sequence of human lactoferrin and their use
EP2060586A1 (en) 2007-11-14 2009-05-20 PharmaSurgics in Sweden AB New synthetic arginine substituted peptides and their use
BRPI0904622A2 (pt) * 2008-05-23 2016-06-21 Asubio Pharma Co Ltd peptídeo com ação de prolongar a meia-vida de um peptídeo de interesse no plasma
EP2387390B1 (en) * 2009-01-13 2012-11-28 PharmaSurgics in Sweden AB Hylauronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation
EP2481751A1 (en) * 2011-01-26 2012-08-01 PharmaSurgics in Sweden AB Human lactoferrin derived peptides
KR101341210B1 (ko) * 2013-01-24 2013-12-12 재단법인 지능형 바이오 시스템 설계 및 합성 연구단 신규한 항균 펩타이드 및 이의 용도

Similar Documents

Publication Publication Date Title
JP2014505061A5 (enExample)
JP2014505062A5 (enExample)
JP2015512386A5 (enExample)
HK1214765A1 (zh) 包含b-raf抑制剂和组蛋白脱乙酰基酶抑制剂的药物组合以及其在治疗增生性疾病中的用途
MX2023012271A (es) Medicina terapeutica para enfermedades fibrosas.
JP2014521735A5 (enExample)
RU2008136324A (ru) Желудочно-кишечный пролиферативный фактор и его применения
EA201590166A8 (ru) Комбинированная терапия для лечения рассеянного склероза
RU2013139294A (ru) Новые синтетические пептиды и их применение
NZ713202A (en) Diagnosis and treatments relating to th2 inhibition
EP4477267A3 (en) Collagen peptide-based medicament compositions for use in the treatment of ocular diseases, disorders or wounds
JP2012041342A5 (enExample)
FI3494972T3 (fi) Dolutegraviirin ja lamivudiinin yhdistelmiä hiv-infektion hoitoon
RU2017127273A (ru) Короткие антимикробные липопептиды
JP2011507845A5 (enExample)
MX356343B (es) Compuestos que inhiben la exocitosis neuronal (ii).
RU2018106533A (ru) Новые изоформы трипсина и их применение
JP2013541583A5 (enExample)
MX353394B (es) Aplicación de dihidroxiclorinas beta-funcionalizadas para tfd.
CN103458912B (zh) 治疗皮肤病的方法
EA201270747A1 (ru) Композиции и способы для профилактики и лечения ран
MX2018013475A (es) Acido carboxilico para tratar/prevenir congestion nasal.
RU2014141515A (ru) Антимикробный перевязочный материал, антимикробный препарат и их применение
EA201500992A1 (ru) Леденец для лечения боли в горле, охриплости голоса и связанного с ней сухого кашля и воспалительных заболеваний полости рта и глотки
JP2015513554A5 (enExample)